Their findings are consistent with the theory that miR-34 controls the capacity of pancreatic cancer stem cells to self-renew and/or decide their own fate, presumably by directly influencing their targets Bcl-2 and Notch. The gene discussed is BCL2; the disease is familial pancreatic carcinoma.